iHSCs With the Gene Correction of HBB Intervent Subjests With β-thalassemia Mutations
Clinical trial NCT03728322 · UNKNOWN
Trial details
- NCT number
- NCT03728322
- Sponsor
- Allife Medical Science and Technology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-01
- Primary completion
- 2020-01-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.